Detalhe da pesquisa
1.
Using Chemical Epigenetics to Target Cancer.
Mol Cell
; 78(6): 1086-1095, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407673
2.
Exploiting polarity and chirality to probe the Hsp90 C-terminus.
Bioorg Med Chem
; 26(12): 3096-3110, 2018 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720349
3.
Deepening biomedical research training: Community-Building Wellness Workshops for Post-Baccalaureate Research Education Program (PREP) Trainees.
bioRxiv
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38559081
4.
Colicin E1 opens its hinge to plug TolC.
Elife
; 112022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199644
5.
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma.
Cancer Discov
; 12(3): 730-751, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34772733
6.
Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors.
J Med Chem
; 64(9): 5787-5801, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872011
7.
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma.
Blood Cancer Discov
; 2(4): 370-387, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258103
8.
N-Methyl-4-phenylpyridinium Scaffold-Containing Lipophilic Compounds Are Potent Complex I Inhibitors and Selective Dopaminergic Toxins.
ACS Chem Neurosci
; 10(6): 2977-2988, 2019 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929447
9.
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma.
Leukemia
; 33(11): 2685-2694, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962579